127 related articles for article (PubMed ID: 16719379)
1. High-performance liquid chromatography analysis of CYP2C8-catalyzed paclitaxel 6alpha-hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():103-7. PubMed ID: 16719379
[TBL] [Abstract][Full Text] [Related]
2. High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():103-107. PubMed ID: 27699666
[TBL] [Abstract][Full Text] [Related]
3. Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():109-13. PubMed ID: 16719380
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomes.
Ma B; Subramanian R; Schrag ML; Rodrigues AD; Tang C
Drug Metab Dispos; 2004 May; 32(5):473-8. PubMed ID: 15100167
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic analysis of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 1998; 107():123-7. PubMed ID: 14577220
[No Abstract] [Full Text] [Related]
6. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
[TBL] [Abstract][Full Text] [Related]
7. CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():115-9. PubMed ID: 16719381
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
Hanioka N; Matsumoto K; Saito Y; Narimatsu S
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
[TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance.
Wattanachai N; Polasek TM; Heath TM; Uchaipichat V; Tassaneeyakul W; Tassaneeyakul W; Miners JO
Eur J Clin Pharmacol; 2011 Aug; 67(8):815-24. PubMed ID: 21305272
[TBL] [Abstract][Full Text] [Related]
10. Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation.
Rowbotham SE; Boddy AV; Redfern CP; Veal GJ; Daly AK
Drug Metab Dispos; 2010 Aug; 38(8):1261-6. PubMed ID: 20421446
[TBL] [Abstract][Full Text] [Related]
11. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():91-6. PubMed ID: 16719377
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6-dependent bufuralol 1'-hydroxylation assayed by reverse-phase ion-pair high-performance liquid chromatography with fluorescence detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():121-5. PubMed ID: 16719382
[TBL] [Abstract][Full Text] [Related]
13. Effect of buffer conditions on CYP2C8-mediated paclitaxel 6α-hydroxylation and CYP3A4-mediated triazolam α- and 4-hydroxylation by human liver microsomes.
Kudo T; Ozaki Y; Kusano T; Hotta E; Oya Y; Komatsu S; Goda H; Ito K
Xenobiotica; 2016; 46(3):241-6. PubMed ID: 26290405
[TBL] [Abstract][Full Text] [Related]
14. Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes.
Vuppugalla R; Chang SY; Zhang H; Marathe PH; Rodrigues DA
Drug Metab Dispos; 2007 Nov; 35(11):1990-5. PubMed ID: 17709370
[TBL] [Abstract][Full Text] [Related]
15. The determination of cytochrome P450 2E1-dependent p-nitrophenol hydroxylation by high-performance liquid chromatography with electrochemical detection.
Mishin VM; Koivisto T; Lieber CS
Anal Biochem; 1996 Jan; 233(2):212-5. PubMed ID: 8789720
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human cytochrome P4502C8 by montelukast.
Walsky RL; Obach RS; Gaman EA; Gleeson JP; Proctor WR
Drug Metab Dispos; 2005 Mar; 33(3):413-8. PubMed ID: 15608135
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of testosterone metabolites in liver microsomes using column-switching semi-microcolumn high-performance liquid chromatography.
Tachibana S; Tanaka M
Anal Biochem; 2001 Aug; 295(2):248-56. PubMed ID: 11488629
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
Tornio A; Pasanen MK; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):104-8. PubMed ID: 15998357
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6α-hydroxylation and amodiaquine N-deethylation.
Tsukada C; Saito T; Maekawa M; Mano N; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Oct; 30(5):366-73. PubMed ID: 26427316
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population.
Hichiya H; Tanaka-Kagawa T; Soyama A; Jinno H; Koyano S; Katori N; Matsushima E; Uchiyama S; Tokunaga H; Kimura H; Minami N; Katoh M; Sugai K; Goto Y; Tamura T; Yamamoto N; Ohe Y; Kunitoh H; Nokihara H; Yoshida T; Minami H; Saijo N; Ando M; Ozawa S; Saito Y; Sawada J
Drug Metab Dispos; 2005 May; 33(5):630-6. PubMed ID: 15716363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
